May 27, 2026 a 07:43 pm
BIIB: Fundamental Ratio Analysis - Biogen Inc.
Biogen Inc. showcases strong potential, driven by its extensive portfolio in the neurological and neurodegenerative therapeutic domain. Despite some challenges in the pharmaceutical industry, Biogen remains a formidable player with solid financials. Investors should keep an eye on its continued development efforts and collaborations.
Fundamental Rating
Biogen Inc. demonstrates a robust fundamental rating, indicating a healthy financial status and business strategy.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow (DCF) | 5 | |
| Return on Equity (ROE) | 4 | |
| Return on Assets (ROA) | 4 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 4 |
Historical Rating
Comparing current and previous fundamental scores highlights key changes in Biogen Inc.'s performance.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | 4 | 5 | 4 | 4 | 2 | 2 | 4 |
Analyst Price Targets
Analysts predict a strong price target range for Biogen, reflecting potential upside.
| High | Low | Median | Consensus |
|---|---|---|---|
| $260 | $143 | $225 | $212.26 |
Analyst Sentiment
Biogen has a favourable analyst sentiment with a noticeable "Buy" consensus.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 28 | |
| Hold | 19 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Biogen Inc. continues to show strong fundamentals and a promising outlook as a key player in the healthcare sector. Despite some financial constraints, their strategic partnerships and robust pipeline offer significant potential for growth. Investors are advised to consider Biogen's consistent performance and innovative endeavours when assessing investment validity. Furthermore, the solid analyst price targets and sentiment highlight potential opportunities for future gains. However, market volatility and industry dynamics should be monitored closely as part of the decision-making process.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years